3 Reasons Rigetti Computing Stock Could Be a Trap, Not a Bargain

Rigetti generated just $4.4 million of Q1 2026 revenue and $5.1 million in Q2, while posting operating losses of $26.0 million and $28.1 million, respectively, underscoring its pre-profit, high-burn profile despite $541.3 million of cash and investments and no debt. Its up-to-$100 million CHIPS Act award includes only $43.9 million initially available, with $56.1 million contingent on technical milestones and potential clawbacks; the related issuance of 7.74 million shares at $12.92 dilutes existing holders. Management expects key systems only in 2027 and says commercially useful quantum advantage remains years away, leaving material execution, timing, and competitive risks.

Analysis

The relevant valuation question for RGTI is not runway but the rate at which cash converts into de-risked, commercially monetizable capability. The federal award principally offsets R&D that would otherwise be shareholder-funded; it does not establish recurring demand or validate a durable unit-economics model. The equity issuance effectively creates a public-sector reference price near $12.92, which may become a technical overhang if the shares trade materially above that level before subsequent milestones are independently validated.

Near term, the stock remains unusually sensitive to milestone headlines, quantum-sector beta, and retail momentum rather than fundamentals. Over the next 1-3 months, disclosure around award conditions, cash use, bookings, and system utilization matters more than incremental qubit announcements; absent evidence of paid workload growth, investors should expect multiple compression whenever attention rotates away from speculative AI-adjacent themes. The key falsifier for a bearish view is a material increase in contracted revenue or backlog with credible gross-margin disclosure, rather than another engineering demonstration.

Second-order, non-dilutive government support improves RGTI's ability to remain relevant in superconducting quantum hardware, but it also raises the competitive bar for peers: IBM and Alphabet can amortize quantum R&D against much larger cloud ecosystems, while IonQ and D-Wave offer different architectures and commercialization narratives. RGTI's real risk is not simply burn; it is that hardware progress becomes commoditized before it owns the cloud distribution, software stack, or enterprise relationships needed to capture downstream economics. Consensus bearish commentary may nevertheless understate optionality: successful milestone completion could remove financing-risk discounts and trigger sharp squeezes in a thin, high-beta name even without near-term profitability.

Key Decisions for Investors

• Do not establish a directional core short solely on this article; borrow availability, elevated retail participation, and milestone-driven gap risk can dominate fundamentals over days to weeks.
• For a 1-3 month tactical bearish expression, prefer defined-risk RGTI put spreads initiated after momentum rallies or ahead of earnings, targeting a retracement toward the government equity reference price of $12.92. Size small; exit if disclosed backlog/contracted revenue materially exceeds expectations or technical milestones are achieved ahead of schedule.
• Relative-value watch: short RGTI versus long IBM only if RGTI's valuation premium expands after a headline-driven rally. IBM provides quantum exposure embedded in a profitable software and infrastructure franchise, reducing architecture-specific and financing risk; reassess if RGTI demonstrates sustained commercial bookings.
• Set an event alert for the next milestone-tranche determination and quarterly cash burn. A failure to access later funding, a burn acceleration without corresponding bookings, or guidance extending system-delivery timing would support downside; confirmed tranche release alone is not sufficient to invalidate the thesis.